menu search

Spexis announces the appointment of gonçalo bernardes, ph.d., as acting head of chemical biology

ALLSCHWIL, Switzerland, Sept. 27, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases...

September 28, 2023, 5:30 am

American oncology network to host investor presentation webcast on september 29

FORT MYERS, Fla., Sept. 27, 2023 (GLOBE NEWSWIRE) — American oncology Network, Inc. (“AON” or the...

September 27, 2023, 8:05 pm

Coherus announces three presentations at the 38th annual meeting of the society for immunotherapy of cancer (sitc)

REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today announced the presentation of three...

September 27, 2023, 1:10 pm

Costco share fall following results, while cardiff oncology and millerknoll shares soar, and more moving stocks

Cardiff oncology Inc. CRDF, +0.62% shares surged 32% on favorable data from two cancer drug trials — ...

September 27, 2023, 5:56 am

Summit therapeutics: not for retail investors

Summit Therapeutics Inc., backed by biotech billionaire Bob Duggan, has transitioned from developing antibiotics to becoming an ...

September 26, 2023, 3:00 pm

Transcode therapeutic stock whipsaws lower after cut price placing

TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monda...

September 26, 2023, 6:47 am

Transcode therapeutics announces pricing of $8 million public offering

BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA ...

September 26, 2023, 12:01 am

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biophar...

September 25, 2023, 11:30 pm

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutica...

September 25, 2023, 7:30 pm

Astrazeneca stock upgraded to buy at jefferies

Shares of biopharmaceutical giant AstraZeneca (AZN) were upgraded to "Buy" from "Hold" at Jefferies. The analyst says assets outside of the company's ...

September 25, 2023, 4:24 pm

Transcode therapeutics stock skyrockets on positive brain cancer trial results

TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug candidate TTX-MC138 in mice mod...

September 25, 2023, 10:38 am

Astrazeneca upgraded on potential for non-oncology assets

AstraZeneca PLC (LSE:AZN)'s assets beyond oncology offer significant upside potential, in the view of i...

September 25, 2023, 9:58 am

Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

September 25, 2023, 9:30 am

Kura's ziftomenib: the swiss army knife in aml therapy

Kura oncology's lead candidate, ziftomenib, shows dual-functionality in treating NPM1-mutant AML and ov...

September 25, 2023, 4:40 am

Moderna is expecting massive growth over the next decade. is the stock a no-brainer buy?

Moderna is investing in such areas as oncology, rare diseases, and infectious diseases. The biotech pro...

September 22, 2023, 8:45 am

Checkpoint therapeutics to participate in the cantor global healthcare conference

WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and...

September 21, 2023, 8:30 am

Affimed to present at the cantor global healthcare conference 2023

MANNHEIM, Germany, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-...

September 21, 2023, 6:30 am

Frontier portfolio company signs collaboration deal with merck

Frontier IP Group PLC (AIM:FIPP), a firm specialising in the commercialisation of intellectual property, announced in an RNS today that its portfolio ...

September 21, 2023, 4:01 am

Oric pharmaceuticals to participate in the 2023 cantor global healthcare conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage ...

September 20, 2023, 4:30 pm

Onkure therapeutics appoints ann howell, pharm.d., as vice president of regulatory affairs

BOULDER, Colo., Sept. 20, 2023 (GLOBE NEWSWIRE) — OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next gener...

September 20, 2023, 1:41 pm


Search within

Pages Search Results: